+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Breast Cancer Diagnostics Market by Technique (Imaging, Molecular Testing, Tissue Biopsy Tests), Cancer Type (BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer), Component, Diagnostic Type, End-User - Forecast 2024-2030- Product Image
Global Breast Cancer Diagnostics Market by Technique (Imaging, Molecular Testing, Tissue Biopsy Tests), Cancer Type (BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer), Component, Diagnostic Type, End-User - Forecast 2024-2030- Product Image
Sale

Global Breast Cancer Diagnostics Market by Technique (Imaging, Molecular Testing, Tissue Biopsy Tests), Cancer Type (BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer), Component, Diagnostic Type, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5206469
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Cancer Diagnostics Market size was estimated at USD 6.54 billion in 2023, USD 7.04 billion in 2024, and is expected to grow at a CAGR of 7.79% to reach USD 11.06 billion by 2030.

Breast cancer diagnostics refer to tests and procedures conducted to determine the stage of breast cancer, including blood tests, magnetic resonance imaging, Positron emission tomography (PET) scan, and computerized tomography (CT scan). Breast cancer diagnostics tests determine whether the cancer or tumor is restricted to the breast or has spread to other body organs such as lymph nodes. The changing lifestyles and dietary and nutrition regime has led to hormonal changes and caused an increase in the number of women diagnosed with breast cancer and necessitated the development of breast cancer diagnostic tests.

Furthermore, government initiatives and incentives to raise awareness about breast cancer and female reproductive health have caused a surge in the number of cancer screening programs worldwide. However, the high costs associated with breast cancer screening tests, genetic testing, and cancer drugs prevent patients from availing the services for treatment and diagnosis of cancer. The lack of skilled personnel to initiate appropriate treatment diagnosis procedures poses significant challenges for cancer care. However, integrating machine learning (ML) and artificial intelligence (AI) in breast cancer diagnostic procedures has enabled early breast cancer diagnosis. AI algorithms can identify missed cancers and breast tissue features and help predict future cancers.

Regional Insights

The American breast cancer diagnostics market is highly developed due to the notable prevalence of breast cancer and the presence of multiple advanced imaging techniques in the region. According to the American Cancer Society, approximately 287,850 new cases of invasive breast cancer were anticipated to be diagnosed in the United States in 2022, bolstering the need for breast cancer diagnosis. Additionally, the growing geriatric population, ongoing cancer-related research activities, and the rising burden of different types of breast cancer have enhanced the need for breast cancer diagnosis in Germany, New Zealand, the United Kingdom, and several other European nations.

Moreover, the significant involvement of the European government in breast cancer detection and diagnosis programs has elevated the market scope. In the Asia-Pacific region, China and India are the most prevalent regions for the increasing cases of breast cancer patients, raising the need for breast cancer diagnostics. Furthermore, the emerging campaigns and breast cancer awareness programs have highlighted the need for breast cancer diagnostics in Asian countries.

Market Trends by Segment

  • Technique: Advancements in molecular and genomic biology advancing the penetration of molecular testing
  • Cancer Type: BRCA breast cancer is highly implicated as a hereditary breast cancer
  • Diagnostic Type: Advancing applications of non-ionizing imaging technologies for breast cancer diagnostics
  • End-User: High adoption of breast cancer diagnostics in the diagnostic laboratories

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Solis Mammography Announces Acquisition of Carolina Breast Imaging

Solis Mammography, a significant provider of specialized women's healthcare, announced its acquisition of Carolina Breast Imaging, a network of three breast imaging centers in eastern North Carolina. This acquisition aims to enhance patient care by offering advanced standards through fellowship-trained breast imaging specialists and state-of-the-art technology.

Johnson & Johnson Impact Ventures Invests in Mamotest to Improve Access to Care for Breast Cancer Patients in Latin America

Johnson & Johnson Impact Ventures invested in Mamotest, signaling their commitment to supporting the company's growth and expansion efforts in Argentina, Mexico, and other countries within the region. Mamotest, an AI-based platform founded in 2012, is dedicated to making early diagnosis of breast cancer accessible to all, aiming to improve survival rates.

Sysmex Europe Distributes MammaTyper, an Advanced Breast Cancer Diagnostic Assay, Through The European Distribution Agreement With Cerca Biotech

Sysmex Europe SE has established a distribution agreement with Cerca Biotech, spanning various markets in the EMEA region, including the UK, Ireland, and several European countries. This agreement aims to incorporate Cerca Biotech's innovative breast cancer diagnostic assay, MammaTyper, into Sysmex's Life Science portfolio.

Key Company Profiles

The report delves into recent significant developments in the Breast Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 4D Path Inc., Abbott Laboratories, Agilent Technologies, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocept, Inc., Biodesix, Cardinal Health, Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc. by Cell Microsystems, FUJIFILM Holdings Corporation, General Electric Company, Hologic, Inc., Illumina, Inc., Koninklijke Philips N.V., NanoString Technologies, Inc., NeoGenomics Laboratories, Olea Medical, OncoGenomX, Paragon Biosciences LLC by Catalent, Inc., Provista Diagnostics, Inc. by Todos Medical, Quest Diagnostics Incorporated, Siemens Healthcare Private Limited, and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Breast Cancer Diagnostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of breast cancer globally
5.1.1.2. Favorable reimbursement framework for breast cancer diagnosis
5.1.1.3. Growing number of breast cancer screening programs worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with breast cancer diagnostic tests
5.1.3. Opportunities
5.1.3.1. Integration of artificial intelligence (AI) and machine learning (ML) in breast cancer diagnostic
5.1.3.2. Ongoing research and development activities in cancer diagnostic techniques
5.1.4. Challenges
5.1.4.1. Dearth of the skilled and trained professionals
5.2. Market Segmentation Analysis
5.2.1. Technique: Advancements in molecular and genomic biology advancing the penetration of molecular testing
5.2.2. Cancer Type: BRCA breast cancer is highly implicated as a hereditary breast cancer
5.2.3. Diagnostic Type: Advancing applications of non-ionizing imaging technologies for breast cancer diagnostics
5.2.4. End-User: High adoption of breast cancer diagnostics in the diagnostic laboratories
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Breast Cancer Diagnostics Market, by Technique
6.1. Introduction
6.2. Imaging
6.3. Molecular Testing
6.4. Tissue Biopsy Tests
7. Breast Cancer Diagnostics Market, by Cancer Type
7.1. Introduction
7.2. BRCA Breast Cancer
7.3. EGFR Mutation Test Breast Cancer
7.4. ER & PR Breast Cancer
7.5. HER 2 Breast Cancer
8. Breast Cancer Diagnostics Market, by Component
8.1. Introduction
8.2. Consumables
8.3. Instruments
9. Breast Cancer Diagnostics Market, by Diagnostic Type
9.1. Introduction
9.2. Ionizing Breast Imaging Technologies
9.3. Non-Ionizing Imaging Technologies
10. Breast Cancer Diagnostics Market, by End-User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals & Ambulatory Surgery Center
10.4. Research & Academic Institutes
11. Americas Breast Cancer Diagnostics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Breast Cancer Diagnostics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Breast Cancer Diagnostics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Solis Mammography Announces Acquisition of Carolina Breast Imaging
14.3.2. Johnson & Johnson Impact Ventures Invests in Mamotest to Improve Access to Care for Breast Cancer Patients in Latin America
14.3.3. Sysmex Europe Distributes MammaTyper, an Advanced Breast Cancer Diagnostic Assay, Through The European Distribution Agreement With Cerca Biotech
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. BREAST CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. BREAST CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BREAST CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BREAST CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. BREAST CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BREAST CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BREAST ULTRASOUND SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PET/CT SCAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY EGFR MUTATION TEST BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER 2 BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY-BASED INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NON-IONIZING IMAGING TECHNOLOGIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 126. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 127. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 128. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 129. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 130. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 131. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 132. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 133. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 134. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 135. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 136. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 137. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 138. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 139. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 142. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 143. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 144. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 145. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 146. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 147. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 148. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 149. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 150. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 151. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 152. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 153. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 154. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 155. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 158. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 163. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 164. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 165. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 166. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 167. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 168. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 169. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 170. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 171. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 174. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 176. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 180. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 182. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 184. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 186. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 188. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 192. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 193. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 194. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 195. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 196. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 197. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 198. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 199. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 200. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 201. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 202. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 203. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 204. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 205. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 206. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 207. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. AUSTRALIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 210. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 211. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 212. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 213. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 214. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 215. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 216. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 217. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 218. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 219. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 220. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 221. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 222. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 223. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. CHINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 226. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 227. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 228. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 229. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 230. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 231. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 232. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 233. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 234. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 235. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 236. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 237. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 238. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 239. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. INDIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 242. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 243. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 244. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 245. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 246. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 247. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 248. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 249. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 250. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 251. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 252. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 253. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 254. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 255. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. INDONESIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 258. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 259. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 260. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 261. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 262. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 263. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 264. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 265. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 266. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 267. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 268. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 269. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 270. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 271. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. JAPAN BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 274. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 275. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 276. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 277. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 278. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 279. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 280. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 281. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 282. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 283. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 284. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 285. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 286. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 287. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. MALAYSIA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 290. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 291. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 292. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 293. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 294. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 295. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 296. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 297. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 298. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 299. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 300. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 301. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 302. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 303. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. PHILIPPINES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 306. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 307. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 308. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 309. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 310. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 311. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 312. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 313. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 314. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 315. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 316. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 317. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2023 (USD MILLION)
TABLE 318. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2024-2030 (USD MILLION)
TABLE 319. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 320. SINGAPORE BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 321. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
TABLE 322. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
TABLE 323. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2023 (USD MILLION)
TABLE 324. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2024-2030 (USD MILLION)
TABLE 325. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH KOREA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COM

Companies Mentioned

  • 4D Path Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocept, Inc.
  • Biodesix
  • Cardinal Health
  • Danaher Corporation
  • Epigenomics AG
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc. by Cell Microsystems
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • NanoString Technologies, Inc.
  • NeoGenomics Laboratories
  • Olea Medical
  • OncoGenomX
  • Paragon Biosciences LLC by Catalent, Inc.
  • Provista Diagnostics, Inc. by Todos Medical
  • Quest Diagnostics Incorporated
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.06 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Global Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Forecast 2024-2030 - Product Image

Global Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 190 Pages
  • Global
From
Global Breast Cancer Screening Market by Technology (Ionizing Breast Imaging Technologies, Non-ionizing Breast Imaging Technologies), Product (Accessories, Breast Imaging Systems, Software & Services), End User - Forecast 2024-2030 - Product Image

Global Breast Cancer Screening Market by Technology (Ionizing Breast Imaging Technologies, Non-ionizing Breast Imaging Technologies), Product (Accessories, Breast Imaging Systems, Software & Services), End User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report by Technology, End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), Region, and Segment Forecasts, 2023-2030 - Product Image

Global Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report by Technology, End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), Region, and Segment Forecasts, 2023-2030

  • Report
  • 120 Pages
  • Global
From
Breast Cancer Diagnostics Global Market Report 2024 - Product Image

Breast Cancer Diagnostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.